Shire’s rare blood disorder drug gets US fast track
admin 23rd March 2017 Uncategorised 0An experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration.
More: Shire’s rare blood disorder drug gets US fast track
Source: News